vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Oportun Financial Corp (OPRT). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $247.7M, roughly 1.1× Oportun Financial Corp). BALCHEM CORP runs the higher net margin — 14.9% vs 1.4%, a 13.5% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs -1.3%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs -0.5%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Oportun Financial Corp is a US-based fintech firm that provides accessible, responsible financial services including personal loans, credit cards, and savings products to underserved low-to-moderate income consumers, many with limited or no credit history, leveraging proprietary AI underwriting to deliver fair terms while mitigating operational risk.
BCPC vs OPRT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $247.7M |
| Net Profit | $40.3M | $3.4M |
| Gross Margin | — | — |
| Operating Margin | 20.5% | 2.6% |
| Net Margin | 14.9% | 1.4% |
| Revenue YoY | 8.1% | -1.3% |
| Net Profit YoY | 8.7% | -61.0% |
| EPS (diluted) | $1.25 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $247.7M | ||
| Q3 25 | $267.6M | $238.7M | ||
| Q2 25 | $255.5M | $234.3M | ||
| Q1 25 | $250.5M | $235.9M | ||
| Q4 24 | $240.0M | $250.9M | ||
| Q3 24 | $239.9M | $250.0M | ||
| Q2 24 | $234.1M | $250.4M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $3.4M | ||
| Q3 25 | $40.3M | $5.2M | ||
| Q2 25 | $38.3M | $6.9M | ||
| Q1 25 | $37.1M | $9.8M | ||
| Q4 24 | $33.6M | $8.7M | ||
| Q3 24 | $33.8M | $-30.0M | ||
| Q2 24 | $32.1M | $-31.0M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 2.6% | ||
| Q3 25 | 20.4% | 6.0% | ||
| Q2 25 | 20.1% | 4.3% | ||
| Q1 25 | 20.4% | 5.6% | ||
| Q4 24 | 19.8% | 89.6% | ||
| Q3 24 | 20.0% | -15.8% | ||
| Q2 24 | 19.6% | -19.6% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 1.4% | ||
| Q3 25 | 15.1% | 2.2% | ||
| Q2 25 | 15.0% | 2.9% | ||
| Q1 25 | 14.8% | 4.1% | ||
| Q4 24 | 14.0% | 200.1% | ||
| Q3 24 | 14.1% | -12.0% | ||
| Q2 24 | 13.7% | -12.4% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.07 | ||
| Q3 25 | $1.24 | $0.11 | ||
| Q2 25 | $1.17 | $0.14 | ||
| Q1 25 | $1.13 | $0.21 | ||
| Q4 24 | $1.03 | $0.26 | ||
| Q3 24 | $1.03 | $-0.75 | ||
| Q2 24 | $0.98 | $-0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $105.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $390.1M |
| Total Assets | $1.7B | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $105.5M | ||
| Q3 25 | $65.1M | $104.6M | ||
| Q2 25 | $65.4M | $96.8M | ||
| Q1 25 | $49.9M | $78.5M | ||
| Q4 24 | $49.5M | $60.0M | ||
| Q3 24 | $73.7M | $71.8M | ||
| Q2 24 | $63.7M | $72.9M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $390.1M | ||
| Q3 25 | $1.3B | $383.9M | ||
| Q2 25 | $1.3B | $376.0M | ||
| Q1 25 | $1.2B | $366.1M | ||
| Q4 24 | $1.1B | $353.8M | ||
| Q3 24 | $1.2B | $327.6M | ||
| Q2 24 | $1.1B | $354.1M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $3.3B | ||
| Q3 25 | $1.7B | $3.2B | ||
| Q2 25 | $1.7B | $3.2B | ||
| Q1 25 | $1.6B | $3.2B | ||
| Q4 24 | $1.6B | $3.2B | ||
| Q3 24 | $1.6B | $3.3B | ||
| Q2 24 | $1.6B | $3.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $413.4M |
| Free Cash FlowOCF − Capex | $33.8M | — |
| FCF MarginFCF / Revenue | 12.5% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | 0.99× | 121.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $413.4M | ||
| Q3 25 | $65.6M | $99.0M | ||
| Q2 25 | $47.3M | $104.5M | ||
| Q1 25 | $36.5M | $101.0M | ||
| Q4 24 | $52.3M | $393.5M | ||
| Q3 24 | $51.3M | $108.5M | ||
| Q2 24 | $45.0M | $107.7M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 121.45× | ||
| Q3 25 | 1.63× | 19.05× | ||
| Q2 25 | 1.23× | 15.20× | ||
| Q1 25 | 0.98× | 10.34× | ||
| Q4 24 | 1.56× | 45.04× | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
